Showing results (1851-1860 of 5,485) with videos related to

Sort By:
Pageof 549
Pancreas|February 13, 2014
Influence of the implantation site on the sensitivity of patient pancreatic tumor xenografts to Apo2L/TRAIL therapyRohit Sharma, Sandra Buitrago, Rose Pitoniak, et al.
Pancreas|January 1, 1988
Effect of L364718, a new CCK antagonist, on amylase secretion in isolated rat pancreatic aciniR Hosotani, P Chowdhury, D McKay, et al.
Pancreas|October 13, 2009
Analysis of prognostic factors in metastatic tumors of the pancreas: a single-center experience and review of the literatureMichele Masetti, Nicola Zanini, Federica Martuzzi, et al.
Pancreas|October 13, 2009
Comparison of plasma Tu-M2-PK and CA19-9 in pancreatic cancerMaiken Thyregod Joergensen, Niels H H Heegaard, Ove B Schaffalitzky de Muckadell
Pancreas|October 14, 2009
TRAF6 as the key adaptor of TLR4 signaling pathway is involved in acute pancreatitisXiang-Yu Zhou, Zong-Guang Zhou, Jun-Li Ding, et al.
Pancreas|January 1, 1988
Free cytosolic calcium and secretagogue-stimulated initial pancreatic exocrine secretionP E Krims, S J Pandol
Pancreas|October 9, 2009
CYP2A13, ADH1B, and ADH1C gene polymorphisms and pancreatic cancer riskBeatrice Mohelnikova-Duchonova, David Vrana, Ivana Holcatova, et al.
Pancreas|October 9, 2009
Independent contribution of common CFTR variants to chronic pancreatitisRafael de Cid, Maria D Ramos, Luís Aparisi, et al.
Pancreas|April 26, 2008
Inhibition of human pancreatic cell line MIA PaCa2 proliferation by HA-But, a hyaluronic butyric ester: a preliminary reportCinzia Pellizzaro, Annalisa Speranza, Sonia Zorzet, et al.
Pancreas|April 26, 2008
A phase II trial of imatinib mesylate in patients with metastatic pancreatic cancerMecide Gharibo, Linda Patrick-Miller, Ling Zheng, et al.
Pageof 549